About us
Who We Are
Medilumina was founded in 2024 by Sandra Gottschalk-Reed, MBA, with a mission to help medical device companies successfully launch and commercialize revolutionary new technologies. Sandra, a graduate of the 2024–2025 Harvard Medical School Executive Education Global Healthcare Leadership Program
Our Mission
At Medilumina, our mission is to accelerate the adoption of innovative and disruptive medical technologies by empowering healthcare innovators with expert-led go-to-market strategies and advanced analytics. We combine deep industry expertise with automated market landscapes, ROI and economic value modeling, and reimbursement and payer intelligence to help organizations make informed decisions. By providing early-stage feasibility and diligence support, we enable our clients to navigate complex healthcare markets, unlock value, and bring impactful medical solutions to patients faster.
Our Vision
Our vision is to become a trusted global partner for healthcare innovators, shaping the future of medical technology commercialization through data-driven insights and strategic guidance. Medilumina aims to bridge the gap between groundbreaking medical innovation and real-world market adoption by delivering actionable intelligence, accelerating market access, and improving patient outcomes. Through continuous innovation and expert collaboration, we strive to create a healthcare ecosystem where transformative technologies reach those who need them most.